Drug Shortage Report for ATHENA-ONDANSETRON ODT
Report ID | 10326 |
Drug Identification Number | 02444674 |
Brand name | SANDOZ ONDANSETRON ODT |
Common or Proper name | SANDOZ ONDANSETRON ODT |
Company Name | ATHENA PHARMACEUTIQUES SAS |
Market Status | MARKETED |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 4MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 1X10 |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-05-05 |
Estimated end date | 2017-07-10 |
Actual end date | 2017-07-10 |
Shortage status | Resolved |
Updated date | 2017-09-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | ESPACE ARNOLD DE VILLE, 12 RUE GEORGES BLANDON LOUVECIENNES, -- FRANCE 78430 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2017-09-07 | French | Compare |
v7 | 2017-09-07 | English | Compare |
v6 | 2017-06-26 | French | Compare |
v5 | 2017-06-26 | English | Compare |
v4 | 2017-06-06 | French | Compare |
v3 | 2017-06-06 | English | Compare |
v2 | 2017-05-15 | French | Compare |
v1 | 2017-05-15 | English | Compare |
Showing 1 to 8 of 8